Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C. G. Tjan‐Heijnen, R. Vree, Irene E.G. van Hellemond et al.|The Lancet Oncology|2017Cited by 158
Costs of complications after colorectal cancer surgery in the Netherlands: Building the business case for hospitalsJohannes A. Govaert, Joost T. Heikens, Michel W.J.M. Wouters et al.|European Journal of Surgical Oncology|2015Cited by 103
Volume‐ or outcome‐based referral to improve quality of care for esophageal cancer surgery in The NetherlandsMichel W.J.M. Wouters, Rob A.�E.�M. Tollenaar, Pieta Krijnen et al.|Journal of Surgical Oncology|2009Cited by 44